Patents by Inventor Claude Fromentin

Claude Fromentin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Patent number: 8178554
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: May 15, 2012
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES
    Publication number: 20110245254
    Abstract: This invention discloses and claims methods for inhibiting bacterial ?-lactamases and treating bacterial infections by inhibiting bacterial ?-lactamases in man or an animal comprising administering a therapeutically effective amount to said man or said animal of a compound, or pharmaceutically acceptable salt thereof, of formula (I) either alone or in combination with a ?-lactamine antibiotic wherein said combination can be administered separately, together or spaced out over time. Pharmaceutical compositions comprising a compound of formula (I), or a combination of a compound of formula (I) and a therapeutically effective amount of a ?-lactamine antibiotic, and a pharmaceutically acceptable carrier are also disclosed and claimed.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 6, 2011
    Applicant: FOREST LABORATORIES HOLDINGS LIMITED
    Inventors: Jozsef Aszodi, Claude Fromentin, Maxime Lampilas, David Alan Rowlands
  • New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Publication number: 20110213147
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Application
    Filed: May 10, 2011
    Publication date: September 1, 2011
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Publication number: 20110021772
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Application
    Filed: April 16, 2010
    Publication date: January 27, 2011
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Patent number: 7732610
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: June 8, 2010
    Assignee: Aventis Pharma S.A.
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES
    Publication number: 20100048528
    Abstract: This invention discloses and claims methods for inhibiting bacterial ?-lactamases and treating bacterial infections by inhibiting bacterial ?-lactamases in man or an animal comprising administering a therapeutically effective amount to said man or said animal of a compound, or pharmaceutically acceptable salt thereof, of formula (I) either alone or in combination with a ?-lactamine antibiotic wherein said combination can be administered separately, together or spaced out over time. Pharmaceutical compositions comprising a compound of formula (I), or a combination of a compound of formula (I) and a therapeutically effective amount of a ?-lactamine antibiotic, and a pharmaceutically acceptable carrier are also disclosed and claimed.
    Type: Application
    Filed: November 2, 2009
    Publication date: February 25, 2010
    Applicant: Novexel
    Inventors: Jozsef Aszodi, Claude Fromentin, Maxime Lampilas, David Alan Rowlands
  • Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Patent number: 7638529
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: December 29, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • Heterocyclic compounds as inhibitors of beta-lactamases
    Patent number: 7612087
    Abstract: This invention discloses and claims methods for inhibiting bacterial ?-lactamases and treating bacterial infections by inhibiting bacterial ?-lactamases in man or an animal comprising administering a therapeutically effective amount to said man or said animal of a compound, or pharmaceutically acceptable salt thereof, of formula (I) either alone or in combination with a ?-lactamine antibiotic wherein said combination can be administered separately, together or spaced out over time. Pharmaceutical compositions comprising a compound of formula (I), or a combination of a compound of formula (I) and a therapeutically effective amount of a ?-lactamine antibiotic, and a pharmaceutically acceptable carrier are also disclosed and claimed.
    Type: Grant
    Filed: July 26, 2004
    Date of Patent: November 3, 2009
    Assignee: Novexel
    Inventors: Jozsef Aszodi, Claude Fromentin, Maxime Lampilas, David Alan Rowlands
  • HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES
    Publication number: 20090215747
    Abstract: This invention discloses and claims methods for inhibiting bacterial ?-lactamases and treating bacterial infections by inhibiting bacterial ?-lactamases in man or an animal comprising administering a therapeutically effective amount to said man or said animal of a compound, or pharmaceutically acceptable salt thereof, of formula (I) either alone or in combination with a ?-lactamine antibiotic wherein said combination can be administered separately, together or spaced out over time. Pharmaceutical compositions comprising a compound of formula (I), or a combination of a compound of formula (I) and a therapeutically effective amount of a ?-lactamine antibiotic, and a pharmaceutically acceptable carrier are also disclosed and claimed.
    Type: Application
    Filed: May 1, 2009
    Publication date: August 27, 2009
    Applicant: Aventis Pharma S.A.
    Inventors: Jozsef Aszodi, Claude Fromentin, Maxime Lampilas, David Alan Rowlands
  • 2-halogenated derivatives of 5-O-desosaminyl-erythronolide A, their preparation process and their antibiotic use
    Patent number: 7119180
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): Wherein the substituents are defined as in the application. The compounds of this invention exhibit antibiotic properties.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: October 10, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin
  • Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
    Patent number: 7112592
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: September 26, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Publication number: 20060189652
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Application
    Filed: February 6, 2006
    Publication date: August 24, 2006
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
    Publication number: 20060046995
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
    Type: Application
    Filed: September 14, 2005
    Publication date: March 2, 2006
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Rowlands, Claude Fromentin
  • 2-Halogenated derivatives of 5-O-desosaminyl-erythronolide a, their preparation process and their antibiotic use
    Publication number: 20050065101
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): Wherein the substituents are defined as in the application. The compounds of this invention exhibit antibiotic properties.
    Type: Application
    Filed: November 12, 2004
    Publication date: March 24, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin
  • Heterocyclic compounds as inhibitors of beta-lactamases
    Publication number: 20050020572
    Abstract: This invention discloses and claims methods for inhibiting bacterial ?-lactamases and treating bacterial infections by inhibiting bacterial ?-lactamases in man or an animal comprising administering a therapeutically effective amount to said man or said animal of a compound, or pharmaceutically acceptable salt thereof, of formula (I) either alone or in combination with a ?-lactamine antibiotic wherein said combination can be administered separately, together or spaced out over time. Pharmaceutical compositions comprising a compound of formula (I), or a combination of a compound of formula (I) and a therapeutically effective amount of a ?-lactamine antibiotic, and a pharmaceutically acceptable carrier are also disclosed and claimed.
    Type: Application
    Filed: July 26, 2004
    Publication date: January 27, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Jozsef Aszodi, Claude Fromentin, Maxime Lampilas, David Rowlands
  • Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
    Publication number: 20030199541
    Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: 1
    Type: Application
    Filed: January 29, 2003
    Publication date: October 23, 2003
    Inventors: Maxime Lampilas, Jozsef Aszodi, David Alan Rowlands, Claude Fromentin
  • Derivatives . . . use as medicaments
    Patent number: 6455505
    Abstract: A subject of the invention is, as new chemical products, the compounds of formula (I) in which X represents a hydrogen atom or a halogen atom and Z represents a hydrogen atom or the remainder of an acid as well as their addition salts with acids. The compounds of formula (I) have antibiotic properties.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: September 24, 2002
    Assignee: Hoechst Marion Roussel
    Inventors: Constantin Agouridas, Alexis Denis, Claude Fromentin
  • 2-halogenated derivatives of 5-0-desosaminyl-erythronolide A, their preparation process and their antibiotic use
    Publication number: 20020111319
    Abstract: Novel compounds of the formula 1
    Type: Application
    Filed: February 13, 2002
    Publication date: August 15, 2002
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin
  • Derivatives of erythromycin, their preparation process and their use as medicaments
    Patent number: 6407257
    Abstract: A subject of the invention is, as new chemical products, the compounds of formula (I) in which X represents a hydrogen atom or a halogen atom and Z represents a hydrogen atom or the remainder of an acid as well as their addition salts with acids. The compounds of formula (I) have antibiotic properties.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: June 18, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Alexis Denis, Claude Fromentin
  • 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
    Patent number: RE39743
    Abstract: Novel compounds of the formula wherein the substituents are defined as in the application having antibiotic properties.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: July 24, 2007
    Assignee: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin